Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma

Clinical trial NCT06708455 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06708455
Sponsor: Rapa Therapeutics LLC
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma With Metastasis Malignant Melanoma Malignant Melanoma Stage IIIc Malignant Melanoma Stage IV

Start date: 2027-03-01
Primary completion: 2029-03-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.